Cate Whittlesea

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

PloS one

British journal of clinical pharmacology

The British journal of general practice : the journal of the Royal College of General Practitioners

Health technology assessment (Winchester, England)

University College London

Cardiff University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Jul 01 2017

United Kingdom

Prof of Pharmacy Practice :: UCL School of Pharmacy

Education History

Cardiff University Sep 30 1992 - Jan 30 1995

United Kingdom

MSC :: School of Social Science

King's College London Oct 01 1987 - Sep 30 1990

United Kingdom

PHD :: Pharmacy

University of Brighton Sep 30 1983 - Jun 30 1986

United Kingdom

BSC :: Pharmacy

Publications

Widya N Insani, Cate Whittlesea, Li Wei
Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study. PloS one 19 (7) (2024)
Widya N Insani, Cate Whittlesea, Li Wei
Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study. PloS one 19 (7) (2024)
Widya N Insani, Cate Whittlesea, Chengsheng Ju, Kenneth Keng Cheung Man, Matthew Adesuyan, Sarah C E Chapman, Li Wei
Impact of ACEIs and ARBs-related adverse drug reaction on patients' clinical outcomes: a cohort study in UK primary care. The British journal of general practice : the journal of the Royal College of General Practitioners (2023)
Kim Donoghue, Sadie Boniface, Eileen Brobbin, Sarah Byford, Rachel Coleman, Simon Coulton, Edward Day, Ranjita Dhital, Anum Farid, Laura Hermann, Amy Louise Jordan, Andreas Kimergård, Maria-Leoni Koutsou, Anne Lingford-Hughes, John Marsden, Joanne Neale, Aimee O'Neill, Thomas Phillips, James Shearer, Julia M A Sinclair, Joanna Smith, Sir John Strang, John Weinman, Cate Whittlesea, Kideshini Widyaratna, Colin Drummond
Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT. Health technology assessment (Winchester, England) 27 (22) (2023)
Tian-Tian Ma, Ian Chi Kei Ck Wong, Cate Whittlesea, Isla S Mackenzie, Kenneth Keng Cheung Man, Wallis C Y Lau, Ruth Brauer, Li Wei
Initial cardiovascular treatment patterns during the first 90 days following an incident cardiovascular event. British journal of clinical pharmacology 87 (3) (2020)

Cate Whittlesea.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cate Whittlesea